DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Bryn Pharma, Inc.
Bryn Pharma, Inc.
Stage unknownLebanon, NJOther Health Care
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Apr 10, 2025Form D equity offering · $4.7M (form d sold) · 105 investorsFact SEC EDGAR Form D data sets (quarterly) · “Bryn Pharma, Inc. filed Form D: $4,692,830 sold of $4,692,830, Other Health Care”
Investors on record
0 edges
No named investor yet.
People
3 officers, 9 directors
- James Borneman Executive Officer sec.gov
- Joshua Ziel Executive Officer sec.gov
- Steven Killmeyer Executive Officer sec.gov
- Anne Whitaker Director Fact
- Michael Kaseta Director Fact
- Jeff Hartness Director Fact
- Steven Hartman Director Fact
- Michelle Lobel Director Fact
- Marc Rapaport Director Fact
- Lisa Licht Director Fact
- Sandra Loreaux Director Fact
- Kate Soper Diaz Director Fact
Timeline
1
- Aug 14, 2025Bryn Pharma, Inc. filed Form D: $4,692,830 sold of $4,692,830, Other Health CareForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
13 observations
Every observation on this company
- Entity type: Corporation Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Health Care Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $4.7M Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $4.7M Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-04-10 Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 105 Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 26 STILL HOLLOW RD, LEBANON, NJ, 08833 Aug 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)